Published on 22 Apr 2022 on Zacks via Yahoo Finance
Integra LifeSciences Holdings Corporation IART has been gaining from robust performance by the Codman Specialty Surgical (CSS) arm. The company’s continued efforts toward portfolio optimization buoy optimism. A strong solvency position is an added advantage. However, stiff competition and foreign exchange headwinds do not bode well.
Over the past year, the Zacks Rank #3 (Hold) stock has declined 14.4%, against the 7.4% fall of the industry. This compares to a 5% rise of the S&P 500.
The renowned medical device company has a market capitalization of $5.31 billion.